BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29087482)

  • 1. Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.
    Spengler JR; Saturday G; Lavender KJ; Martellaro C; Keck JG; Nichol ST; Spiropoulou CF; Feldmann H; Prescott J
    J Infect Dis; 2017 Dec; 217(1):58-63. PubMed ID: 29087482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.
    Spengler JR; Lavender KJ; Martellaro C; Carmody A; Kurth A; Keck JG; Saturday G; Scott DP; Nichol ST; Hasenkrug KJ; Spiropoulou CF; Feldmann H; Prescott J
    J Infect Dis; 2016 Oct; 214(suppl 3):S308-S318. PubMed ID: 27601621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice.
    Escudero-Pérez B; Ruibal P; Rottstegge M; Lüdtke A; Port JR; Hartmann K; Gómez-Medina S; Müller-Guhl J; Nelson EV; Krasemann S; Rodríguez E; Muñoz-Fontela C
    JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31550241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
    Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.
    Bird BH; Spengler JR; Chakrabarti AK; Khristova ML; Sealy TK; Coleman-McCray JD; Martin BE; Dodd KA; Goldsmith CS; Sanders J; Zaki SR; Nichol ST; Spiropoulou CF
    J Infect Dis; 2016 Mar; 213(5):703-11. PubMed ID: 26582961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice.
    Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G
    J Virol; 2019 May; 93(10):. PubMed ID: 30814283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
    Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
    J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B & L are not required for ebola virus replication.
    Marzi A; Reinheckel T; Feldmann H
    PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Factors Involved in Ebola Virus Replication.
    Rasmussen AL
    Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
    Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
    J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.
    Wong G; Qiu X; de La Vega MA; Fernando L; Wei H; Bello A; Fausther-Bovendo H; Audet J; Kroeker A; Kozak R; Tran K; He S; Tierney K; Soule G; Moffat E; Günther S; Gao GF; Strong J; Embury-Hyatt C; Kobinger G
    J Infect Dis; 2016 Oct; 214(suppl 3):S281-S289. PubMed ID: 27651412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.
    Kindrachuk J; Wahl-Jensen V; Safronetz D; Trost B; Hoenen T; Arsenault R; Feldmann F; Traynor D; Postnikova E; Kusalik A; Napper S; Blaney JE; Feldmann H; Jahrling PB
    J Virol; 2014 Sep; 88(17):9877-92. PubMed ID: 24942569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.
    Alfson KJ; Avena LE; Beadles MW; Staples H; Nunneley JW; Ticer A; Dick EJ; Owston MA; Reed C; Patterson JL; Carrion R; Griffiths A
    J Virol; 2015 Jul; 89(13):6773-81. PubMed ID: 25903348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques.
    Martins K; Cooper C; Warren T; Wells J; Bell T; Raymond J; Stuthman K; Benko J; Garza N; van Tongeren S; Donnelly G; Retterer C; Dong L; Bavari S
    Viral Immunol; 2015 Feb; 28(1):32-41. PubMed ID: 25514385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of a Guinea Pig-Adapted Sudan Virus.
    Wong G; He S; Wei H; Kroeker A; Audet J; Leung A; Cutts T; Graham J; Kobasa D; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Jan; 90(1):392-9. PubMed ID: 26491156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.
    Strong JE; Wong G; Jones SE; Grolla A; Theriault S; Kobinger GP; Feldmann H
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17982-7. PubMed ID: 18981410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 20. Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species.
    Kurosaki Y; Ueda MT; Nakano Y; Yasuda J; Koyanagi Y; Sato K; Nakagawa S
    J Gen Virol; 2018 Feb; 99(2):181-186. PubMed ID: 29300152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.